Sat.Oct 15, 2022 - Fri.Oct 21, 2022

article thumbnail

Boston University researchers’ testing of lab-made version of Covid virus draws government scrutiny

STAT

Research at Boston University that involved testing a lab-made hybrid version of the SARS-CoV-2 virus is garnering heated headlines alleging the scientists involved could have unleashed a new pathogen. There is no evidence the work, performed under biosecurity level 3 precautions in BU’s National Emerging Infectious Diseases Laboratories, was conducted improperly or unsafely.

364
364
article thumbnail

5 impactful drug trial failures from the last year

PharmaVoice

Major recent trial flops and what they mean for companies, patients and the industry.

299
299
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Parliament square set for ME research demonstration

Pharma Times

Demonstrators will demand hundreds of millions of pounds ‘missing’ from ME research

166
166
article thumbnail

Thérèse Coffey criticised for giving leftover antibiotics to a friend

The Guardian - Pharmaceutical Industry

Health secretary accused of ‘monumental stupidity’ for saying she had shared a prescribed medication Doctors have rounded on the health secretary, Thérèse Coffey, after she admitted to sharing prescription medicines with others, actions the British Medical Association described as both dangerous and against the law. Coffey told civil servants in a meeting last month that she had given leftover antibiotics to a poorly friend, an admission that came as the discussion on how to alleviate pressures

145
145
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

CDC: Signs point to an early start for flu season, with cases already ticking up in parts of the U.S.

STAT

Before the Covid-19 pandemic emerged, influenza trackers would begin reading tea leaves around this time of the year, looking for signs of whether there would be an early start to the flu season in the northern hemisphere and which of the various flu viruses might be responsible for the most cases over the coming winter. Flu transmission has been low since the start of the pandemic , but an odd spurt of activity in April, May, and even early June of 2022 — which coincided with the onset o

349
349
article thumbnail

What’s keeping pharma leaders up at night

PharmaVoice

C-suite execs in the life sciences share their late-night thoughts including innovation, patient access and market factors.

279
279

More Trending

article thumbnail

EMCrit 335 – APRV TCAV for Lung Rescue Made Simple with Rory Spiegel

EMCrit Project

Every Resus doc should be able to crash a patient on to APRV for lung rescue. EMCrit Project by Scott Weingart, MD FCCM.

143
143
article thumbnail

Could monkeypox infections have long-term consequences?

STAT

Since the world began confronting a global outbreak of monkeypox in the spring, the scientific community has had plenty of reasons to rue the fact that for decades this virus has been understudied. Here’s another one: Because of that oversight, doctors treating people who have been infected with monkeypox can’t answer with certainty whether some of them will face any long-term health consequences, referred to as sequelae in the field of medicine.

331
331
article thumbnail

J&J reveals just how much economic turbulence is affecting Big Pharma

PharmaVoice

The healthcare giant showed pharmaceutical gains, but that's no thanks to the economic environment of persistent inflation and a strong U.S. dollar.

264
264
article thumbnail

AlzeCure gets new Alzheimer's abstract accepted

Pharma Times

Therapy is based on ACD856's indicative disease modifying effects against the condition

161
161
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Tackling immune-mediated disease with CAR Tregs

European Pharmaceutical Review

In recent years there has been significant development within the cell therapy field, as chimeric antigen receptor (CAR) T-cell therapy demonstrated an ability to transform the treatment of patients with haematological malignancies. Recognising the potential of CAR T cells to act as highly targeted therapeutics, several biotechnology companies – including Sangamo Therapeutics – have established development pipelines of CAR T regulatory cells (Tregs) that aim to tackle immune?

Immunity 140
article thumbnail

STAT+: What to know about Roche’s experimental Alzheimer’s treatment

STAT

The next big Alzheimer’s disease study readout is almost here. Roche is nearing the completion of a pair of clinical trials involving its experimental treatment called gantenerumab. The Swiss pharma giant will announce results from the studies within the next six weeks.

297
297
article thumbnail

How a company aimed at bringing the woolly mammoth back to life spun off a startup that could speed drug development

PharmaVoice

Colossal Biosciences announced the creation of Form Bio — and its “operating system for science” — in September.

article thumbnail

Grifols’ Tavlesse receives NICE recommendation

Pharma Times

Therapy treats refractory chronic immune thrombocytopenia and is available across UK

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Could SIBO Be Preventing Your Remission from Hashimoto’s?

The Thyroid Pharmacist

Many people with Hashimoto’s feel significantly better when they remove reactive foods, replenish nutrient depletions with restorative foods and supplements, and support the gut with probiotics. But what if those steps alone don’t work? You’ll have to dig a bit deeper. It took more than the implementation of the strategies above for me to resolve all my symptoms related to Hashimoto’s.

Dosage 131
article thumbnail

BU lab wasn’t required to clear potentially controversial study with NIH, director says

STAT

The director of a Boston University laboratory that conducted potentially controversial research on the viruses that cause Covid-19 said his institution didn’t clear the work with the National Institutes of Health because it wasn’t funded by the federal agency. Ronald Corley said the research, which was designed to explore what makes some SARS-CoV-2 viruses more or less pathogenic, was funded with money from the university itself.

292
292
article thumbnail

Woman of the Week: Exscientia’s Charlotte Deane

PharmaVoice

Is the industry ready for a biologic discovery revolution? Charlotte Deane, chief scientist of biologics AI at Exscientia, thinks so.

246
246
article thumbnail

Apogenix’s asunercept demonstrates efficacy in COVID-19 trial

Pharma Times

Therapy showed faster clinical recovery for combined treatment groups

150
150
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Text message therapy for depression works in young adults

pharmaphorum

Young adults with depression have been treated effectively with a cognitive behavioural therapy (CBT) course – delivered via text message – in a pilot study conducted by researchers in the US. The trial looked at a four-week CBT course adapted from a face-to-face programme to work via text messages, followed by a four-week follow-up period, in around 100 young adults in the US with at least one symptom of moderate depression and no recent history of antidepressant therapy.

120
120
article thumbnail

Opinion: UpToDate has a racism problem. Its name is Dr. Stanley Goldfarb

STAT

The University of Pennsylvania’s Division of Renal-Electrolyte and Hypertension recently made a quiet update to its history web page : it removed all references to its former co-chief, Dr. Stanley Goldfarb. For several years, Goldfarb has been a vocal critic of considering social determinants of health, racism, and anything else he considers too “woke” in medical education or health care at large.

287
287
article thumbnail

Think your company could be on HHS’ drug price negotiation list? Here’s how to navigate next steps

PharmaVoice

Know what to expect from the CMS over the next few months as it implements the drug reforms laid out in the Inflation Reduction Act.

article thumbnail

Kite and Refuge Biotechnologies to work together to research blood cancer

Pharma Times

The licence agreement bolsters Kite’s expertise in synthetic biology for oncology

149
149
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Frontiers Health 2022 – day 2

pharmaphorum

And the LIVE coverage continues as we head into Day Two… This day is set to hold even more points of interest, with the demonstration ‘CX innovation: building experiences that work for customers’ (moderated by Healthware Group’s global head of digital strategy and customer engagement Yannick Valenti), as well as the masterclass ‘How to maximise learning science to affect behaviour change’ with Meducate Global’s president, Lawrence Sherman, and MD of Healthware MedComms & SWM, Francis M

119
119
article thumbnail

STAT+: Milestone Pharma’s nasal spray rapidly restores normal heart rhythm, achieving goal of key study

STAT

Milestone Pharmaceuticals said Monday that an experimental nasal-spray medicine acted quickly to treat people experiencing episodes of a rapid but non-fatal heart rate — more than doubling the conversion to normal heart rhythm and achieving the primary goal of a late-stage clinical trial. The medicine, called etripamil , is meant to treat people with paroxysmal supraventricular tachycardia, or PSVT, a condition characterized by episodes of rapid heartbeat that suddenly start and stop.

article thumbnail

He helped discover BMS’s psoriasis pill Sotyktu. Here’s what he has to say about early science in Big Pharma

PharmaVoice

Bristol Myers Squibb’s senior principal scientist Ryan Moslin shares why his team was built for success and how they ushered a potential psoriasis blockbuster through discovery.

246
246
article thumbnail

NHS Confederation responds to the appointment of Jeremy Hunt

Pharma Times

New Chancellor of the Exchequer left in no doubt regarding challenges ahead

144
144
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Lilly agrees to acquire gene therapy developer Akouos for $610m

Pharmaceutical Technology

Eli Lilly and Company has signed a definitive agreement for the acquisition of all outstanding shares of precision genetic medicine firm Akouos for a total deal value of up to nearly $610m or up to $15.50 for each share in cash. The deal comprises an acquisition value of $12.50 for each share in cash payable at closing along with one non-tradeable contingent value right per share (CVR) of up to another $3 in cash.

119
119
article thumbnail

Justice Department sues Cigna for allegedly exaggerating conditions of Medicare Advantage members

STAT

The Department of Justice filed a new lawsuit against Cigna Monday, alleging the health insurance company overcharged the federal government by purposefully inflating how sick its Medicare Advantage members were. The decision is a change of heart from federal prosecutors, who originally declined to intervene in the whistleblower case back in 2020.

article thumbnail

The Novartis US Foundation’s president on the ‘magical piece’ of its 10-year health equity plan

PharmaVoice

Dr. Patrice Matchaba discusses Novartis’ end-to-end approach to tackling systemic health disparities.

246
246
article thumbnail

Cancer diagnoses decrease across England during 2020

Pharma Times

Statistics show an average of 789 new malignant cancers diagnosed per day in 2020

137
137
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.